Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Gabon has been steadily increasing in recent years.
Customer preferences: Gabonese customers have shown a growing interest in preventive healthcare measures, including vaccination. The government has also been actively promoting vaccination campaigns to improve public health outcomes. As a result, more and more individuals and families are seeking out vaccines to protect themselves and their loved ones.
Trends in the market: The vaccines market in Gabon has been expanding in response to the growing demand. This has led to increased competition among vaccine manufacturers and distributors, resulting in a wider range of products and more competitive pricing. In addition, there has been a shift towards more specialized vaccines, such as those for specific diseases or age groups.
Local special circumstances: Gabon has a relatively small population, which presents unique challenges for vaccine distribution. However, the government has been working to improve access to vaccines by partnering with healthcare providers and community organizations to bring vaccines to remote areas. Additionally, there is a growing trend towards private healthcare in Gabon, which has led to an increase in demand for vaccines from private clinics and hospitals.
Underlying macroeconomic factors: Gabon is a middle-income country with a relatively stable economy. The government has invested heavily in healthcare infrastructure and services in recent years, which has contributed to the growth of the vaccines market. Additionally, Gabon has a relatively high rate of infectious diseases, which has increased awareness of the importance of vaccination among the population. Overall, the vaccines market in Gabon is expected to continue to grow in the coming years as the government and private sector continue to invest in preventive healthcare measures.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
